Cboe UK EUR

Danaher Corporation (DAPD.XC)

169.46

0.00

(0.00%)

As of April 15 at 3:38:17 PM GMT+1. Market Open.

Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow

Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organizations in the gene editing, mRNA vaccine and therapeutics, viral gene therapy, and modified gene therapy spaces; today announced, a joint marketing agreement aimed at enhancing the workflow solutions for cell therapy manufacturers. The collaboration will focus on the joint promotion of the synergies achieved by combining the Aldveron Nanopla

PR Newswire 6 days ago

DHR
Danaher predicts $350M tariff hit, moves to mitigate impact on profits

The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the impact of the tariffs.

MedTech Dive 12 days ago

DHR
Danaher price target lowered to $240 from $260 at Goldman Sachs

Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Danaher (DHR) to $240 from $260 but keeps a Buy rating on the shares after its Q1 results. The company’s Bioprocessing business continues to improve, and the current tariff headwind appears manageable, the analyst tells investors in a research note. Despite the top and bottom line beat in the quarter however, there is still merit in the prudent approach with Danaher maintaining prior FY25 guidance given all the moving parts a

TipRanks 12 days ago

DHR
Danaher Corporation (DHR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential

We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other top stocks in Bill Gates’ portfolio with huge upside potential. Bill Gates became the youngest billionaire back in 1987 when he took […]

Insider Monkey 12 days ago

DHR
BLCO or DHR: Which Is the Better Value Stock Right Now?

BLCO vs. DHR: Which Stock Is the Better Value Option?

Zacks 12 days ago

BHC

DHR
Danaher First Quarter 2025 Earnings: Beats Expectations

Danaher ( NYSE:DHR ) First Quarter 2025 Results Key Financial Results Revenue: US$5.74b (flat on 1Q 2024). Net income...

Simply Wall St. 13 days ago

DHR
Danaher Corp (DHR) Q1 2025 Earnings Call Highlights: Strong Bioprocessing Growth Amidst Mixed ...

Danaher Corp (DHR) reports robust bioprocessing growth and improved profitability, despite challenges in Life Sciences and Diagnostics segments.

GuruFocus.com 13 days ago

DHR
Q1 2025 Danaher Corp Earnings Call

Q1 2025 Danaher Corp Earnings Call

Thomson Reuters StreetEvents 13 days ago

DHR
DHR Q1 Earnings: Bioprocessing Momentum and Tariff Strategy Drive Guidance Above Expectations

Diversified science and technology company Danaher (NYSE:DHR) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $5.74 billion. Guidance for next quarter’s revenue was better than expected at $5.92 billion at the midpoint, 1.4% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 14.4% above analysts’ consensus estimates.

StockStory 13 days ago

DHR
S&P Behemoth Danaher Surges On Plans To Navigate Pharma-Tied Tariffs

Danaher stock jumped Tuesday after the medical powerhouse delivered a "solid" first-quarter report and maintained its outlook for the year.

Investor's Business Daily 13 days ago

DHR
Danaher (DHR) Stock Trades Up, Here Is Why

Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after the company reported impressive first quarter 2025 results, which beat analysts' organic revenue and EPS expectations. Revenue was flat year-over-year on a core basis, which masked a 7% gain in biotech and a modest decline in life sciences, revealing the uneven recovery across business lines. Looking ahead, sales guidance for the next quarter was ahead, while full year EPS guidance

StockStory 13 days ago

DHR
Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Down Y/Y

DHR's first-quarter sales decrease 1% year over year, due to the lackluster performance of its Life Sciences and Biotechnology segments.

Zacks 13 days ago

DHR

PNR

VMI
Danaher Fiscal First-Quarter Results Top Views; Forecasts Core Revenue Growth

Danaher (DHR) on Tuesday reported better-than-expected fiscal first-quarter results, while the medic

PREMIUM
MT Newswires 13 days ago

DHR
Danaher (DHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks 13 days ago

DHR
Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates

Danaher (DHR) delivered earnings and revenue surprises of 16.05% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 14 days ago

DHR

AVTR
Danaher (NYSE:DHR) Surprises With Q1 Sales, Next Quarter’s Sales Guidance is Optimistic

Diversified science and technology company Danaher (NYSE:DHR) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $5.74 billion. Guidance for next quarter’s revenue was better than expected at $5.92 billion at the midpoint, 1.9% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 14.4% above analysts’ consensus estimates.

StockStory 14 days ago

DHR
Danaher: Q1 Earnings Snapshot

WASHINGTON (AP) — Danaher Corp. DHR) on Tuesday reported first-quarter profit of $954 million. The Washington-based company said it had profit of $1.32 per share.

Associated Press Finance 14 days ago

DHR
Danaher Reports First Quarter 2025 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 28, 2025.

PR Newswire 14 days ago

DHR
Danaher Gears Up to Post Q1 Earnings: Is a Beat in Store?

DHR's first-quarter earnings are likely to have been aided by strength in the Biotechnology segment. However, weakness in the Diagnostics and Life Sciences segments are expected to have hurt.

Zacks 14 days ago

DHR
Danaher (DHR) To Report Earnings Tomorrow: Here Is What To Expect

Diversified science and technology company Danaher (NYSE:DHR) will be announcing earnings results tomorrow morning. Here’s what to look for.

StockStory 14 days ago

DHR

Performance Overview

Return	DAPD.XC	S&P 500 (^GSPC)
YTD	-24.27%	-3.93%
1-Year	-25.44%	+10.19%
3-Year	-16.92%	+36.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Danaher Corporation (DAPD.XC)

Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow

Danaher predicts $350M tariff hit, moves to mitigate impact on profits

Danaher price target lowered to $240 from $260 at Goldman Sachs

Danaher Corporation (DHR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential

BLCO or DHR: Which Is the Better Value Stock Right Now?

Danaher First Quarter 2025 Earnings: Beats Expectations

Danaher Corp (DHR) Q1 2025 Earnings Call Highlights: Strong Bioprocessing Growth Amidst Mixed ...

Q1 2025 Danaher Corp Earnings Call

DHR Q1 Earnings: Bioprocessing Momentum and Tariff Strategy Drive Guidance Above Expectations

S&P Behemoth Danaher Surges On Plans To Navigate Pharma-Tied Tariffs

Danaher (DHR) Stock Trades Up, Here Is Why

Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Down Y/Y

Danaher Fiscal First-Quarter Results Top Views; Forecasts Core Revenue Growth

Danaher (DHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates

Danaher (NYSE:DHR) Surprises With Q1 Sales, Next Quarter’s Sales Guidance is Optimistic

Danaher: Q1 Earnings Snapshot

Danaher Reports First Quarter 2025 Results

Danaher Gears Up to Post Q1 Earnings: Is a Beat in Store?

Danaher (DHR) To Report Earnings Tomorrow: Here Is What To Expect

Performance Overview